Rivaroxaban-induced hair loss

Basile Chrétien¹, Anne Besnard¹, Marion Sassier¹, Claire Le Hello², Antoine Coquerel^{1

3

4}, Joachim Alexandre^{1

3

5

6}, Sophie Fedrizzi⁷

Affiliations

¹ Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France.
² Department of Vascular Medicine, CHU de Caen, Caen, 14000, France.
³ Medical School, Université de Caen Normandie, Caen, 14000, France.
⁴ Inserm, U1075 COMETE, Medical School, Caen, 14000, France.
⁵ EA 4650 Signalisation, électrophysiologie et Imagerie des Lésions d'ischémie-reperfusion Myocardique, Université de Caen Normandie, Caen, 14000, France.
⁶ Department of Cardiology, CHU de Caen, Caen, 14000, France.
⁷ Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France. fedrizzi-s@chu-caen.fr.

Case Reports

Basile Chrétien et al. Eur J Clin Pharmacol. 2015 Nov.

. 2015 Nov;71(11):1413-4.

doi: 10.1007/s00228-015-1927-7. Epub 2015 Aug 25.

Basile Chrétien¹, Anne Besnard¹, Marion Sassier¹, Claire Le Hello², Antoine Coquerel^{1

3

4}, Joachim Alexandre^{1

3

5

6}, Sophie Fedrizzi⁷

¹ Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France.
² Department of Vascular Medicine, CHU de Caen, Caen, 14000, France.
³ Medical School, Université de Caen Normandie, Caen, 14000, France.
⁴ Inserm, U1075 COMETE, Medical School, Caen, 14000, France.
⁵ EA 4650 Signalisation, électrophysiologie et Imagerie des Lésions d'ischémie-reperfusion Myocardique, Université de Caen Normandie, Caen, 14000, France.
⁶ Department of Cardiology, CHU de Caen, Caen, 14000, France.
⁷ Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France. fedrizzi-s@chu-caen.fr.

No abstract available

References